Henrietta Lacks

Henrietta Lacks
Name	Henrietta Lacks
Birth date	August 1, 1920
Birth place	Roanoke, Virginia, United States
Death date	October 4, 1951
Death place	Baltimore, Maryland, United States
Occupation	Tobacco farmer, homemaker
Known for	HeLa cell line

Henrietta Lacks was an African American woman whose cervical cancer cells, taken without her informed consent in 1951, became the first immortalized human cell line widely used in biomedical research. Her cells, known as HeLa, enabled breakthroughs across virology, oncology, cell biology, vaccine development and molecular biology, while raising enduring questions about medical ethics, patient consent, and racial disparities in United States medical institutions.

Early life and background

Born near Roanoke, Virginia and raised in Clinton (now Fairmont), Virginia, she moved to Baltimore, Maryland during the Great Migration era and worked as a tobacco farmer and homemaker in the rural Southern United States before relocating to the city. She married David Lacks and had five children; the family included notable figures in African American community life in Baltimore County, Maryland and maintained ties to institutions such as Johns Hopkins University through medical care. Her upbringing took place against the backdrop of Jim Crow laws and the segregated healthcare system of Maryland and the broader Segregation in the United States context.

Diagnosis and treatment

In 1951 she sought care for abnormal bleeding at Johns Hopkins Hospital, one of the few major hospitals serving African Americans at the time and associated with physicians like Howard Jones and laboratories influenced by researchers such as George Gey at the Gey Laboratory. Physicians diagnosed her with aggressive cervical carcinoma and performed procedures including biopsy and radiation therapy at Johns Hopkins Hospital clinics overseen by staff connected to Johns Hopkins School of Medicine. Clinical practices then were shaped by contemporaries in American medicine and intersected with research agendas influenced by institutions like the National Institutes of Health and private research labs.

HeLa cell development and scientific impact

Cells taken from her tumor were cultured by researcher George Otto Gey and propagated into the first immortal human cell line, which was distributed widely and used in experiments at laboratories including those at Cold Spring Harbor Laboratory, Salk Institute for Biological Studies, Rockefeller University, and universities such as University of Pennsylvania and Massachusetts Institute of Technology. HeLa cells played central roles in development of the polio vaccine by Jonas Salk, research into human papillomavirus and oncogenes, advances in in vitro fertilization methodologies, contributions to the emerging field of molecular genetics, and experiments aboard NASA missions studying cell behavior in microgravity. The line enabled large-scale projects like the Human Genome Project and was used in drug screening by pharmaceutical companies such as Pfizer and research consortia at the National Institutes of Health.

Ethical issues and consent controversies

The use of her cells without explicit informed consent became a focal point in debates involving bioethics committees, scholars in the tradition of The Belmont Report principles, and legal scholars influenced by cases such as Moore v. Regents of the University of California. Critics highlighted disparities in treatment of African American patients in institutions like Johns Hopkins Hospital and systemic issues tied to Tuskegee syphilis study–era abuses. The controversy prompted ethical scrutiny from organizations such as the American Medical Association and influenced revisions in research ethics embodied by guidelines from the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research and regulations like the Common Rule.

Family, recognition, and legacy

Her surviving family, including children Deborah, Lawrence, and Zakariyya, engaged with journalists and authors such as Rebecca Skloot and activists who worked with institutions like Sankofa community groups to seek recognition and safeguards. Publications including Skloot’s book and media portrayals in outlets like NPR, The New York Times, and PBS brought wider public attention, while academic discussions in journals at Johns Hopkins University Press and conferences at Columbia University and University of California, Berkeley framed her story within histories of medicine, race, and science. Several institutions and awards, including exhibitions at Smithsonian Institution and panels at National Institutes of Health events, have since acknowledged her impact and the contributions of her family.

Legal and policy outcomes

Debates surrounding ownership of biological materials and patient autonomy influenced legal frameworks and policy changes in research oversight, contributing to revisions in federal regulations administered by agencies such as the Department of Health and Human Services and policy discussions in the United States Congress. In the early 21st century, negotiations between the family and entities connected with National Institutes of Health and Johns Hopkins University led to data-access arrangements and recognition efforts, reflecting shifts toward greater protections advocated by scholars referencing cases like Schloendorff v. Society of New York Hospital and standards promoted by organizations such as the World Medical Association. Her case remains central in courses at institutions like Harvard University and Yale University that teach research ethics and law.

Category:People from Baltimore Category:African American history Category:Medical ethics